MicroRNA profiling of epstein-barr virus-associated NK/T-cell lymphomas by deep sequencing

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Motsch, Natalie ^a   Alles, Julia ^a   Imig, Jochen ^a   Zhu, Jiayun ^b   Barth, Stephanie ^a   Reineke, Tanja ^c   Tinguely, Marianne ^c   Cogliatti, Sergio ^d   Dueck, Anne ^e   Meister, Gunter ^b,e   Renner, Christoph ^c   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Institute of Pathology   (Switzerland)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; MICRORNA; MICRORNA 142 3P; MICRORNA 205; PROTEIN BCL 6; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REPRESSION; HUMAN; HUMAN TISSUE; MOLECULAR LIBRARY; NK T CELL LYMPHOMA; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SEQUENCE ANALYSIS; SMALL RNA LIBRARY; T CELL LYMPHOMA; THYMUS;

CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-1ALPHA; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MICRORNAS; RNA, NEOPLASM; SEQUENCE ANALYSIS, RNA;

HUMAN HERPESVIRUS 4; SIMPLEXVIRUS;

EID: 84864538295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042193     Document Type: Article

References (59)

1. Delecluse HJ, Feederle R, O'Sullivan B, Taniere P, (2007) Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J Clin Pathol 60: 1358-1364.
2. Rickinson AB, Kieff E (2007) Epstein-Barr Virus. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott-Raven. 2655-2700.
3. Hutzinger R, Feederle R, Mrazek J, (2009) Schiefermeier N, Balwierz PJ, et al (2009) Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 5: e1000547.
4. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, et al. (2004) Identification of virus-encoded microRNAs. Science 304: 734-736.
5. Grundhoff A, Sullivan CS, Ganem D, (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. Rna 12: 733-750. Epub 2006 Mar 2015.
6. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2: e23. Epub 2006 Mar 2024.
7. Lytle JR, Yario TA, Steitz JA, (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A 104: 9667-9672.
8. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
9. Meister G, (2007) miRNAs get an early start on translational silencing. Cell 131: 25-28.
10. Godshalk SE, Bhaduri-McIntosh S, Slack FJ, (2008) Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle 7: 3595-3600.
11. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, et al. (2009) Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83: 3333-3341.
12. Aozasa K, Takakuwa T, Hongyo T, Yang WI, (2008) Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 87: 110-117.
13. Meneses-Garcia A, Betancourt AM, Abarca JH, Montes AB, Roa LS, et al. (2008) Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas. World J Surg Oncol 6: 114.
14. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, et al. (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68: 1436-1442.
15. Kim do N, Chae HS, Oh ST, Kang JH, Park CH, et al. (2007) Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81: 1033-1036.
16. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, et al. (2010) Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One 5: e9685.
17. Harabuchi Y, Takahara M, Kishibe K, Moriai S, Nagato T, et al. (2009) Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol 14: 181-190.
18. Zhang Y, Ohyashiki JH, Takaku T, Shimizu N, Ohyashiki K, (2006) Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer 94: 599-608.
19. Liang Y, Ridzon D, Wong L, Chen C, (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166.
20. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, et al. (2004) MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res 14: 2486-2494.
21. O'Leary HM, Savage KJ, (2009) Update on the World Health Organization classification of peripheral T-cell lymphomas. Curr Hematol Malig Rep 4: 227-235.
22. Nozad Charoudeh H, Tang Y, Cheng M, Cilio CM, Jacobsen SE, et al. (2010) Identification of an NK/T cell-restricted progenitor in adult bone marrow contributing to bone marrow- and thymic-dependent NK cells. Blood 116: 183-192.
23. Ng SB, Yan J, Huang G, Selvarajan V, Tay JL, et al. (2011) Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood 118: 4919-4929.
24. Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, et al. (2011) microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 39: 1880-1893.
25. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
26. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004. Epub 2004 Feb 2918.
27. Tie J, Pan Y, Zhao L, Wu K, Liu J, et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879.
28. Gao C, Zhang Z, Liu W, Xiao S, Gu W, et al. (2010) Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 116: 41-49.
29. Korpal M, Lee ES, Hu G, Kang Y, (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
30. Szczyrba J, Loprich E, Wach S, Jung V, Unteregger G, et al. (2010) The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing. Mol Cancer Res 8: 529-538.
31. Cicatiello L, Mutarelli M, Grober OM, Paris O, Ferraro L, et al. (2010) Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 176: 2113-2130.
32. Apte RN, Voronov E, (2008) Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev 222: 222-241.
33. Huang YT, Sheen TS, Chen CL, Lu J, Chang Y, et al. (1999) Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. Cancer Res 59: 1599-1605.
34. Huang B, Zhao J, Lei Z, Shen S, Li D, et al. (2009) miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 10: 180-185.
35. Sung SS, Walters JA, (1991) Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes. J Clin Invest 88: 1915-1923.
36. Huang Y, de Reynies A, de Leval L, Ghazi B, Martin-Garcia N, et al. (2011) Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 115: 1226-1237.
37. Papadopoulou V, Postigo A, Sanchez-Tillo E, Porter AC, Wagner SD, (2010) ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus. Biochem J 427: 541-550.
38. Carbone A, Gloghini A, Gaidano G, Dalla-Favera R, Falini B, (1997) BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas. Blood 90: 2445-2450.
39. Kerl K, Vonlanthen R, Nagy M, Bolzonello NJ, Gindre P, et al. (2001) Alterations on the 5' noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin lymphomas. Lab Invest 81: 1693-1702.
40. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, et al. (2002) The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A 99: 2860-2865.
41. Phan RT, Dalla-Favera R, (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432: 635-639.
42. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R, (2005) BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 6: 1054-1060.
43. Wu W, Lin Z, Zhuang Z, Liang X, (2009) Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 18: 50-55.
44. Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA, (2009) MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. Cancer Res 69: 3278-3282.
45. Feng M, Yu Q, (2010) miR-449 regulates CDK-Rb-E2F1 through an auto-regulatory feedback circuit. Cell Cycle 9: 213-214.
46. Spizzo R, Nicoloso MS, Croce CM, Calin GA, (2009) SnapShot: MicroRNAs in Cancer. Cell 137: 586-586 e581.
47. Sachdeva M, Mo YY, (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70: 378-387.
48. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, et al. (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83: 2357-2367.
49. Jun SM, Hong YS, Seo JS, Ko YH, Yang CW, et al. (2008) Viral microRNA profile in Epstein-Barr virus-associated peripheral T cell lymphoma. Br J Haematol.
50. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, et al. (2003) A uniform system for microRNA annotation. Rna 9: 277-279.
51. Denny CT, Yoshikai Y, Mak TW, Smith SD, Hollis GF, et al. (1986) A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci. Nature 320: 549-551.
52. Hinuma Y, Konn M, Yamaguchi J, Wudarski DJ, Blakeslee JR Jr, et al. (1967) Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol 1: 1045-1051.
53. Lenoir GM, Vuillaume M, Bonnardel C, (1985) The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci Publ. pp. 309-318.
54. Kagami Y, Nakamura S, Suzuki R, Iida S, Yatabe Y, et al. (1998) Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus. Br J Haematol 103: 669-677.
55. Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, et al. (1998) Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Blood 92: 1374-1383.
56. Gong JH, Maki G, Klingemann HG, (1994) Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8: 652-658.
57. Habig M, Smola H, Dole VS, Derynck R, Pfister H, et al. (2006) E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity. Arch Virol 151: 1961-1972.
58. Pall GS, Codony-Servat C, Byrne J, Ritchie L, Hamilton A, (2007) Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot. Nucleic Acids Res 35: e60.
59. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408.